These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16394116)

  • 21. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association.
    Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Chen C
    Gynecol Oncol; 2006 Dec; 103(3):891-6. PubMed ID: 16806437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coffee consumption and the risk of endometrial cancer: Evidence from a case-control study of female hormone-related cancers in Japan.
    Hirose K; Niwa Y; Wakai K; Matsuo K; Nakanishi T; Tajima K
    Cancer Sci; 2007 Mar; 98(3):411-5. PubMed ID: 17270030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
    Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
    Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.
    Saltzman BS; Doherty JA; Hill DA; Beresford SA; Voigt LF; Chen C; Weiss NS
    Am J Epidemiol; 2008 Mar; 167(5):607-14. PubMed ID: 18071194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported stress and risk of endometrial cancer: a prospective cohort study.
    Nielsen NR; Strandberg-Larsen K; Grønbaek M; Kristensen TS; Schnohr P; Zhang ZF
    Psychosom Med; 2007 May; 69(4):383-9. PubMed ID: 17470667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of obesity and HER-2 polymorphisms as risk factors for endometrial cancer in Korean women.
    Tong SY; Ha SY; Ki KD; Lee JM; Lee SK; Lee KB; Kim MK; Cho CH; Kwon SY
    BJOG; 2009 Jul; 116(8):1046-52. PubMed ID: 19438491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medical topics. Estrogens and endometrial cancer].
    Shibusawa K
    Kango; 1981 Oct; 33(11):126. PubMed ID: 6915242
    [No Abstract]   [Full Text] [Related]  

  • 28. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri).
    Daniels AB; Liu GT; Volpe NJ; Galetta SL; Moster ML; Newman NJ; Biousse V; Lee AG; Wall M; Kardon R; Acierno MD; Corbett JJ; Maguire MG; Balcer LJ
    Am J Ophthalmol; 2007 Apr; 143(4):635-41. PubMed ID: 17386271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case-control study of coffee consumption and the risk of endometrial endometrioid adenocarcinoma.
    Koizumi T; Nakaya N; Okamura C; Sato Y; Shimazu T; Nagase S; Niikura H; Kuriyama S; Tase T; Ito K; Tsubono Y; Okamura K; Yaegashi N; Tsuji I
    Eur J Cancer Prev; 2008 Aug; 17(4):358-63. PubMed ID: 18562962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
    Gehrig PA; Cantrell LA; Shafer A; Abaid LN; Mendivil A; Boggess JF
    Gynecol Oncol; 2008 Oct; 111(1):41-5. PubMed ID: 18694588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in O6-methylguanine DNA methyltransferase and endometrial cancer risk.
    Han J; Hankinson SE; De Vivo I
    Carcinogenesis; 2006 Nov; 27(11):2281-5. PubMed ID: 16777993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps?
    Nappi L; Indraccolo U; Di Spiezio Sardo A; Gentile G; Palombino K; Castaldi MA; Spinelli M; Greco P
    J Minim Invasive Gynecol; 2009; 16(2):157-62. PubMed ID: 19162559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes and risk of endometrial cancer: a population-based prospective cohort study.
    Friberg E; Mantzoros CS; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):276-80. PubMed ID: 17301260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
    Canonico M; Oger E; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    J Thromb Haemost; 2006 Jun; 4(6):1259-65. PubMed ID: 16706969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced risk of endometrial cancer from alcohol drinking in Japanese.
    Hosono S; Matsuo K; Kajiyama H; Hirose K; Suzuki T; Hiraki A; Kawase T; Kidokoro K; Nakanishi T; Hamajima N; Kikkawa F; Tajima K; Tanaka H
    Cancer Sci; 2008 Jun; 99(6):1195-201. PubMed ID: 18422741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
    Hanifi-Moghaddam P; Sijmons B; Ott MC; van Ijcken WF; Nowzari D; Kuhne EC; van der Spek P; Kloosterboer HJ; Burger CW; Blok LJ
    J Mol Endocrinol; 2006 Dec; 37(3):405-13. PubMed ID: 17170081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.